MLM Medical Labs News and Insights
24 August 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
31 July 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
03 June 2025
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce...
Read More
31 May 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
22 May 2025
MLM Medical Labs Approved by French Ministry for R&D and Innovation Tax Incentives
Decision strengthens...
Read More
06 May 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
23 April 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
01 April 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
Read More
17 March 2025
Digital Pathology represents a revolutionary convergence of tissue research and technology, catalyzing...
Read More
11 March 2025
MLM Medical Labs – Germany Awarded 6th Consecutive CAP Accreditation for Service Excellence
MÖNCHENGLADBACH,...
Read More
August 24, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
July 31, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
June 3, 2025
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce...
May 31, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
May 22, 2025
MLM Medical Labs Approved by French Ministry for R&D and Innovation Tax Incentives
Decision strengthens...
May 6, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
April 23, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
April 1, 2025
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid...
March 17, 2025
Digital Pathology represents a revolutionary convergence of tissue research and technology, catalyzing...
March 11, 2025
MLM Medical Labs – Germany Awarded 6th Consecutive CAP Accreditation for Service Excellence
MÖNCHENGLADBACH,...
No posts found